NIPH Clinical Trials Search

Health Workforce Education Study of COVID-19 Antiviral Drugs.

Basic Information

Recruitment status	Pending
Health condition(s) or Problem(s) studied	none
Date of first enrollment	28/04/2025
Target sample size	50
Countries of recruitment
Study type	Interventional
Intervention(s)	1. Educational Seminars - Content: COVID-19 Clinical Practice Guidelines, Proper Use of Oral Antiviral Drugs, and Case Review-Format: 60-Minute Face-to-Face Study Group or Web Video Streaming - Instructor: Physicians Involved in Infectious Diseases - Distribution Method: Provided by Face-to-Face or Online Platform * Educational Seminars are Conducted in a Single Session 2. Prescription Support Tools-Format: A4-Size Prescription Decision Flow Chart (for Use in Consultation Offices) - Content: Determination of Indications, Contraindications, and Confirmation of Drug Interactions of COVID-19 Oral Antiviral Drugs - Distribution Method: Provided by Paper Media and Electronic File

Outcome(s)

Primary Outcome

Changes in Prescription Behaviors of Healthcare Professionals (Assessed by Questionnaire Surveys Before and After Intervention) Specifically, changes in scores of questionnaire surveys including the following indicators: - Perceptions of Indications for COVID-19 Oral Antiviral Drugs - Process of Appropriate Prescription Decisions - Drug Interaction Confirmation Behaviors - Implementation of Adverse Drug Reaction Monitoring.

Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender
Include criteria	1.Medical professionals such as physicians, nurses, and pharmacists working in clinics and hospitals within the study area 2.Medical professionals who may be involved in COVID-19 medical care and oral antiviral drug prescription 3.Those who have given their consent to participate in the study 4.Those who are able to participate in educational seminars or watch web-based videos during the study period 5.Those who are able to contact them by e-mail and answer electronic questionnaires.
Exclude criteria	1.Those who are expected to have difficulty in continuous participation due to transfer, retirement, etc. during the study period 2.Those who have difficulty in participating in the educational seminar (if neither face-to-face nor web-delivered participation is available) 3.Those who are unable to cooperate in completing the questionnaire 4.Those who belong to a department or job type completely unrelated to COVID-19 medical care.